Results 151 to 160 of about 48,102 (276)

Exploratory Analysis of Biomarkers Predictive or Reflective of Ninjin'yoeito Efficacy in Patients With Loss of Appetite or Apathy Attributable to Dementia

open access: yesTraditional &Kampo Medicine, Volume 13, Issue 2, August 2026.
ABSTRACT Aim This study explored biomarkers related to patient characteristics and the efficacy of Ninjin'yoeito (NYT), a traditional Japanese Kampo medicine, by conducting omics (metabolomic and microbiomic) analyses of plasma and stool samples obtained during a randomized controlled trial targeting anorexia and apathy in patients with dementia ...
Masashi Tamura   +10 more
wiley   +1 more source

Low Serum Cholinesterase Levels Predict Poor Prognosis in Patients with Ovarian Cancer [PDF]

open access: yes
Hailan Su,1,* Danfeng Liao,2,* Chaolin Huang,2 Qin Liu,3 Lingfang Yu1 1Department of Gynecology, Suzhou Ninth People’s Hospital, Suzhou, People’s Republic of China; 2Department of Gynecology and Obstetrics, The First Affiliated Hospital of ...
Huang C, Yu L, Liu Q, Liao D, Su H
core   +1 more source

Staging concept for aging management: Definition, mechanism, and coping strategies

open access: yesVIEW, Volume 7, Issue 4, August 2026.
We divided the overall aging stage into “pre‐aging”, “aging compensation”, and “aging disability”. For each stage, we delineate the clinical presentations, biological phenomena, theoretical underpinnings, and key management priorities. Abstract Aging, as a gradual and largely irreversible biological process, characterized by declining organismal ...
Zhonghan Wang   +6 more
wiley   +1 more source

Cholinesterase of skeletal muscle and its subcellular components. [PDF]

open access: yes
The cholinesterase activity of skeletal muscle and its subcellular components, including motor endplates, was compared chemically in human, mouse and rat.
Fujii, Masafumi, Namba, Tatsuji
core  

Biomarker‐Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease‐Modifying Treatments: A Consensus Statement by Belgian Experts

open access: yesEuropean Journal of Neurology, Volume 33, Issue 8, August 2026.
ABSTRACT Background The recent approval of disease‐modifying therapies (DMTs) for early Alzheimer's disease (AD) marks a major shift in clinical practice. Biomarker confirmation of amyloid pathology is now required alongside clinical assessment, and blood‐based tests are improving accessibility.
Tim Van Langenhove   +31 more
wiley   +1 more source

The Effect of Pyrethroid Ingestion on Butyrylcholinesterase Level. [PDF]

open access: yesEur J Case Rep Intern Med
Al Katrib E   +3 more
europepmc   +1 more source

Renin‐Angiotensin System Inhibitor Use and Mortality in Older Hypertensive Patients With and Without Dementia: A Nationwide Registry‐Based Cohort Study

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 8, August 2026.
ABSTRACT Cardiovascular risk factors are often undertreated in patients with dementia. Renin‐angiotensin system inhibitors (RASI) are first‐line treatments for hypertension. We examined the association between RASI and all‐cause mortality in hypertensive patients with and without dementia, comparing angiotensin‐converting enzyme inhibitors (ACEI) to ...
Marta Villa Lopez   +14 more
wiley   +1 more source

Studies on Cholinesterase

open access: yesThe Tohoku Journal of Experimental Medicine, 1951
Okinaka, Shigeo   +5 more
openaire   +6 more sources

Home - About - Disclaimer - Privacy